A case of High GAMMA GLUTAMYL TRANSFERASE (GGT)

Gumma glutamyl transferase is an enzyme that catalyzes the transfer of gamma-glutamyl function groups from molecules of aminoalkanoic acid or water. This transferase is found in many tissues, like the Liver, Kidney, Heart Brain, Spleen, etc. It is a diagnostic marker for the diseases or damage of before organs.. the traditional range of GGT is < 55 U/L of blood. If it's quite 160 U/L in blood, indicates definitely organ damage.

CASE STUDY of High GAMMA GLUTAMYL TRANSFERASE

Mr. A Chatterjee,  42/Male,  NIVA PARK P O BORAL, KOLKATA 700154

PRESENT COMPLAINTS

Chronic Alcoholism
Trembling the figures
Dementia ( Acute memory loss )
Irritability 
Deviate Lipid profile
All complaints since last 5 years

PAST HISTORY

Alcohol intake for last 10 years and much quantity until sense less

GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY  130 U/l < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY  57.6 U/l < 37

ALANINE TRANSAMINASE (SGPT) PHOTOMETRY  72.2 U/l 13-40

Deviated lipid profile
TOTAL CHOLESTEROL PHOTOMETRY 217 mg/dl 125-200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 49 mg/dl 35-80
LDL CHOLESTEROL - DIRECT PHOTOMETRY 119 mg/dl 85-130
TRIGLYCERIDES PHOTOMETRY 252 mg/dl 25-200
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.4 Ratio 3 - 5
LDL / HDL RATIO CALCULATED 2.4 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 50.34 mg/dl 5 - 40
NON-HDL CHOLESTEROL CALCULATED 168 mg/dl < 160

Mental tension

GENERALITIES

Chilly, does not like fan.

Aversion to chilies

Sweat, especially on trunk and face and much

Desires for salted food, meat, warm food, eggs, raw onion, Alcohol

Thirst, moderate.

Mind, Suppressed anger, Irritability. short temper

Obesity

CLINICAL

BP- 130/90 mm hg

Pulse- 70/min

Chest- Clear

Heart- S1>S2 audible(R)

Tongue- clean

Weight- 90kgs

INVESTIGATION

Blood for RE, LFT, LIPID PROFILE, TSH, T3, T4, TOTAL PARAMETERS

1st Prescription [ 31/03/2018 ]

CHELLIDONIUM 6X two drops twice daily morning and evening 

CARDUUS M Q 10 drops twice daily before lunch and dinner.

CHOLESTERINUM 200  two drops daily morning and evening. 

Continue for 2 months

2nd Prescription [ 01/06/2018 ]

SAME PRESCRIPTION 

REPEAT ALL

The patient felt better.

continue for 3 months more

3rd Prescription [ 05/10/2018 ]

Investigate again with USG of the whole abdomen

Previous and Recent reports are attached herewith

Continue Chellidonium M 6x for one month more in the same manner then stop for one month, again continue for one month then stop after repeat investigation.

The patient is fit to serve.

REPORT ONE 06/04/2018

TEST NAME TECHNOLOGY UNITS
HbA1c - (HPLC - NGSP Certified)
ADRISH CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED HEMOGRAM - 6 PART (DIFF), HBA

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL ,KOLKATA 700154
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703
VALUE
PROCESSED AT :
HbA1c H.P.L.C 6.3 %
Reference Range :
Below 6.0% - Normal Value
6.0% - 7.0% - Good Control
7.0% - 8.0% - Fair Control
8.0% - 10% - Unsatisfactory Control
Above 10% - Poor Control
Method: Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 134 mg/dl
Reference Range :
90 - 120 mg/dl : Excellent Control
121 - 150 mg/dl : Good Control
151 - 180 mg/dl : Average Control
181 - 210 mg/dl : Action Suggested
> 211 mg/dl : Panic Value
(Note: Average Blood Glucose value is calculated from HBA1c value and it indicates Average Blood Sugar level
over past three months.)
Method: Derived from HBA1c values
Please correlate with clinical conditions.
EDTA
07 Apr 2018 07:29
07 Apr 2018 03:59
:06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr.Prachi Sinkar MD Dr.Caesar Sengupta MD
Barcode: H7113134
Lab code : 060456373/BT009 Page : 1 of 8
TEST NAME-VALUE UNITS REFERENCE RANGE
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED HEMOGRAM - 6 PART (DIFF), HBA

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL  KOLKATA 700154
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703
PROCESSED AT :
TOTAL LEUCOCYTES COUNT 8.81 X 10³ / μL 4.0-10.0
NEUTROPHILS 67.1 % 40-80
LYMPHOCYTE PERCENTAGE 26.6 % 20-40
MONOCYTES 3.2 % 0-10
EOSINOPHILS 2.5 % 0.0-6.0
BASOPHILS 0.3 % <2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT 5.9 X 10³ / μL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 2.34 X 10³ / μL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.28 X 10³ / μL 0.2-1
BASOPHILS - ABSOLUTE COUNT 0.03 X 10³ / μL 0-0.1
EOSINOPHILS - ABSOLUTE COUNT 0.22 X 10³ / μL 0-0.5
IMMATURE GRANULOCYTES(IG) 0.04 X 10³ / μL 0-0.3
TOTAL RBC 5.4 X 10^6/μL 4.5-5.5
NUCLEATED RED BLOOD CELLS Nil X 10³ / μL <0.01
NUCLEATED RED BLOOD CELLS % Nil % <0.01
HEMOGLOBIN 16.9 g/dL 13-17
HEMATOCRIT(PCV) 47.32 % 40-50
MEAN CORPUSCULAR VOLUME(MCV) 102.6 fL 83-101
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 31.3 pq 27-32
MEAN CORP.HEMO.CONC(MCHC) 30.5 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.1 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.7 % 11.6-14
PLATELET DISTRIBUTION WIDTH(PDW) 10.2 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12
PLATELET COUNT 344 X 10³ / μL 150-400
PLATELET TO LARGE CELL RATIO(PLCR) 20.7 % 19.7-42.4
PLATELETCRIT(PCT) 0.32 % 0.19-0.39
Method: Fully automated bidirectional analyzer (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focusing (DC method), Flow Cytometry
Method (using a semiconductor laser), and SLS- hemoglobin method)
Please Correlate with clinical conditions.
EDTA
07 Apr 2018 07:29
07 Apr 2018 03:59
: 06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr.Prachi Sinkar MD Dr.Caesar Sengupta MD
Barcode: H7113134
Lab code : 060456373/BT009
Page: 2 of 8
TEST NAME TECHNOLOGY UNITS
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1.2

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL  KOLKATA 700154
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
VALUE
PROCESSED AT :
IRON PHOTOMETRY 123.7 μg/dl
Reference Range :
Male: 65 - 175
Female : 50 - 170
Method: FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 416.7 μg/dl
Reference Range :
Male: 225 - 535 μg/dl Female: 215 - 535 μg/dl
Method: SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 29.69 %
Reference Range :
13 - 45
Method: DERIVED FROM IRON AND TIBC VALUES
Please correlate with clinical conditions.
SERUM
06 Apr 2018 19:23
06 Apr 2018 16:49
:06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD Dr.Caesar Sengupta MD
Barcode: H9188755
Lab code : 060428686/BT009 Page : 3 of 8
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1.2

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL OPPOSITE TO MAJUMDER CYCLE NEAR
RAKSHIT MORE KOLKATA 700154
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
ALKALINE PHOSPHATASE PHOTOMETRY 136.69 U/l 53 - 128
BILIRUBIN -DIRECT PHOTOMETRY 0.22 mg/dl < 0.3
BILIRUBIN - TOTAL PHOTOMETRY 0.7 mg/dl 0.3-1.2
BILIRUBIN (INDIRECT) CALCULATED 0.48 mg/dl 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 130 U/l < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 57.6 U/l < 37
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 72.2 U/l 13-40
PROTEIN - TOTAL PHOTOMETRY 7.85 gm/dl 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.65 gm/dl 3.2-4.8
SERUM GLOBULIN PHOTOMETRY 3.2 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.45 Ratio 0.9 - 2
Please correlate with clinical conditions.
Method :
ALKP - Modified IFCC method
BILD - Vanadate Oxidation
BILT - Vanadate Oxidation
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - Modified IFCC method
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
Page: 4 of 8
SERUM
06 Apr 2018 19:23
06 Apr 2018 16:49
: 06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Barcode: H9188755
Lab code : 060428686/BT009 Dr. S.Bera MD Dr.Caesar Sengupta MD
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1.2

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL KOLKATA 700154
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
TOTAL CHOLESTEROL PHOTOMETRY 217 mg/dl 125-200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 49 mg/dl 35-80
LDL CHOLESTEROL - DIRECT PHOTOMETRY 119 mg/dl 85-130
TRIGLYCERIDES PHOTOMETRY 252 mg/dl 25-200
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.4 Ratio 3 - 5
LDL / HDL RATIO CALCULATED 2.4 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 50.34 mg/dl 5 - 40
NON-HDL CHOLESTEROL CALCULATED 168 mg/dl < 160
Please correlate with clinical conditions.
Method :
CHOL - CHOD POD METHOD
HCHO - ENZYME SELECTIVE PROTECTION METHOD
LDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY
TRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - Derived from serum HDL and LDL Values
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
NHDL - Derived from serum Cholesterol and HDL values
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL
VERY HIGH >190
HIGH 160-189 VERY HIGH >500
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
(mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
Page : 5 of 8
SERUM
06 Apr 2018 19:23
06 Apr 2018 16:49
: 06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Barcode: H9188755
Lab code: 060428686/BT009 Dr. S.Bera MD Dr.Caesar Sengupta MD
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
NAME
CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1.2

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL OPPOSITE TO MAJUMDER CYCLE NEAR
RAKSHIT MORE KOLKATA 700154
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 7.4 mg/dl 7 - 25
CREATININE - SERUM PHOTOMETRY 0.72 mg/dl 0.6-1.1
URIC ACID PHOTOMETRY 6.8 mg/dl 3.7 - 9.2
CALCIUM PHOTOMETRY 10.25 mg/dl 8.8-10.6
BUN / SR. CREATININE RATIO CALCULATED 10.28 Ratio 9:1-23:1
Please correlate with clinical conditions.
Method :
BUN - KINETIC UV ASSAY.
SCORE - CREATININE ENZYMATIC METHOD
URIC - Uricase / Peroxidase Method
CALC - ARSENAZO III METHOD, END POINT.
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
Page: 6 of 8
SERUM
06 Apr 2018 19:23
06 Apr 2018 16:49
: 06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Barcode: H9188755
Lab code: 060428686/BT009 Dr. S.Bera MD Dr.Caesar Sengupta MD
TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE
NAME
CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1.2

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL  KOLKATA 700154
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 131 ng/dl 60-200
TOTAL THYROXINE (T4) C.L.I.An 8.8 μg/dl 4.5-12
THYROID-STIMULATING HORMONE (TSH) C.L.I.A 1.70 μIU/ml 0.3-5.5
Comments :
Please correlate with clinical conditions.
Method :
T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNOASSAY
T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNOASSAY
TSH - ULTRA SENSITIVE SANDWICH CHEMI LUMINESCENT IMMUNOASSAY
SUGGESTING THYRONORMALCY
SERUM
06 Apr 2018 19:23
06 Apr 2018 16:49
: 06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD Dr.Caesar Sengupta MD
Barcode: H9188755
Lab code: 060428686/BT009
Page: 7 of 8
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1.2

SAMPLE COLLECTED AT :
NIVA PARK P O BORAL  KOLKATA 700154
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED mL/min/1.73 m2
Reference Range:-
115
> = 90 : Normal
60 - 89: Mild Decrease
45 - 59: Mild to Moderate Decrease
30 - 44: Moderate to Severe Decrease
15 - 29: Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild
and moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical
laboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of
renal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate
and feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum
creatinine, age, race, and sex. This provides easy to interpret information for the doctor and patient on the degree of
renal impairment since it approximately equates to the percentage of kidney function remaining. Application of
CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and
management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular
filtration rate. Ann Intern Med. 2009;150(9):604-12.
Please correlate with clinical conditions.
Method:- CKD-EPI Creatinine Equation
~~ End of report ~~
SERUM
06 Apr 2018 19:23
06 Apr 2018 16:49
: 06 Apr 2018 08:51

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD Dr.Caesar Sengupta MD
Barcode: H9188755
Lab code: 060428686/BT009
Page: 8 of 8

REPORT SECOND 13/10/2018
FULLY RECOVERED
NAME
A CHATTERJEE(42Y/M)
REF. BY  DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
TEST NAME TECHNOLOGY VALUE UNITS
LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY mg/dl
Reference Range:-
16.25
Adults : < 30.0 mg/dl
Interpretation:
Determination of LPA may be useful to guide the management of individuals with a family history of CHD or with existing
disease. The levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively
large and hence for diagnostic purpose, results should always be assessed in conjunction with the patient’s medical
history, clinical examination, and other findings.
Specifications:
Precision: Intra Assay (%CV): 3.4 %, Inter Assay (%CV): 2.0 %; Sensitivity: 0.002 gm/l
External Quality Control Program Participation:
College of American Pathologists: General Chemistry and TDM; CAP Number: 7193855-01
Kit Validation References:
Koschinsky ML, Marcovina SM. Lipoprotein A: Structural Implication for Pathophysiology. Int J Clin Lab Res, 1997; 27:
14-23.
Please correlate with clinical conditions.
Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
: 13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode: I9946283
Lab code: 131029399/BT009
Page: 1 of 9
TEST NAME TECHNOLOGY UNITS
NAME
A CHATTERJEE(42Y/M)
REF. BY  DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
VALUE
PROCESSED AT :
APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 98 mg/dL
Reference Range :
Male: 86 - 152
Female : 94 - 162
Method: FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 81 mg/dL
Reference Range :
Male: 56 - 145
Female : 53 - 138
Method: FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.8 Ratio
Reference Range :
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method: DERIVED FROM SERUM APO A1 AND APO B VALUES
Please correlate with clinical conditions.
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
:13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode: I9946283
Lab code: 131029399/BT009 Page: 2 of 9
NAME
CHATTERJEE(42Y/M)
REF. BY  DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
TEST NAME TECHNOLOGY VALUE UNITS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY mg/L
Reference Range:-
1.98
Adult : <=3.0 mg/L
Interpretation:
High sensitivity C-reactive protein, when used in conjunction with other clinical laboratory evaluations of acute coronary
syndromes, may be useful as an independent marker of prognosis for recurrent events, in patients with stable coronary
disease or acute coronary syndromes. hs-CRP levels should not be substituted for the assessment of traditional
cardiovascular risk factors. Patients with persistently unexplained, marked evaluation of hsCRP after repeated testing
should be evaluated for non - cardiovascular etiologies
Clinical significance:
hsCRP measurements may be used as an independent risk marker for the identification of individuals at risk for future
cardiovascular disease. Elevated CRP values may be indicative of the prognosis of individuals with acute coronary
syndromes, and may be useful in the management of such individuals.
Specifications: Precision: Within run %CV has been recorded <=5%.
References:
1. Chenillot O, Henny J, Steinmetz J, et al. High sensitivity C-reactive protein: biological variations and reference limits.
Clin Chem Lab Med 2000;38:1003-11.
2. Hind CRH, Pepys MB. The role of serum C-reactive protein measurements in clinical practice. Int Med 1984;5:112-51.
Please correlate with clinical conditions.
Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
: 13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode: I9946283
Lab code: 131029399/BT009
Page : 3 of 9
TEST NAME TECHNOLOGY UNITS
NAME
CHATTERJEE(42Y/M)
REF. BY  DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
VALUE
PROCESSED AT :
IRON PHOTOMETRY 70.9 μg/dl
Reference Range :
Male: 65 - 175
Female : 50 - 170
Method: FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 398.3 μg/dl
Reference Range :
Male: 225 - 535 μg/dl Female: 215 - 535 μg/dl
Method: SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 17.8 %
Reference Range :
13 - 45
Method: DERIVED FROM IRON AND TIBC VALUES
Please correlate with clinical conditions.
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
:13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode: I9946283
Lab code: 131029399/BT009 Page: 4 of 9
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE , PO- BORAL
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
ALKALINE PHOSPHATASE PHOTOMETRY 110.15 U/l 53 - 128
BILIRUBIN -DIRECT PHOTOMETRY 0.21 mg/dl < 0.3
BILIRUBIN - TOTAL PHOTOMETRY 0.68 mg/dl 0.3-1.2
BILIRUBIN (INDIRECT) CALCULATED 0.47 mg/dl 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 37.6 U/l < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 23.8 U/l < 37
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 28.7 U/l 13-40
PROTEIN - TOTAL PHOTOMETRY 7.31 gm/dl 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.5 gm/dl 3.2-4.8
SERUM GLOBULIN PHOTOMETRY 2.81 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.6 Ratio 0.9 - 2
Please correlate with clinical conditions.
Method :
ALKP - MODIFIED IFCC METHOD
BILD - VANADATE OXIDATION
BILT - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
Page: 5 of 9
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
: 13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Barcode: I9946283
Lab code: 131029399/BT009 Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
TOTAL CHOLESTEROL PHOTOMETRY 172 mg/dl 125-200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 37 mg/dl 35-80
LDL CHOLESTEROL - DIRECT PHOTOMETRY 123 mg/dl 85-130
TRIGLYCERIDES PHOTOMETRY 118 mg/dl 25-200
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.7 Ratio 3 - 5
LDL / HDL RATIO CALCULATED 3.4 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 23.54 mg/dl 5 - 40
NON-HDL CHOLESTEROL CALCULATED 135.23 mg/dl < 160
Please correlate with clinical conditions.
Method :
CHOL - CHOD POD METHOD
HCHO - ENZYME SELECTIVE PROTECTION METHOD
LDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY
TRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL
VERY HIGH >190
HIGH 160-189 VERY HIGH >500
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
(mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
Page : 6 of 9
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
: 13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Barcode: I9946283
Lab code: 131029399/BT009 Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 138 ng/dl 60-200
TOTAL THYROXINE (T4) C.L.I.An 8.7 μg/dl 4.5-12
THYROID-STIMULATING HORMONE (TSH) C.L.I.A 1.89 μIU/ml 0.3-5.5
Comments :
Please correlate with clinical conditions.
Method :
T3 - COMPETITIVE CHEMILUMINESCENT IMMUNOASSAY
T4 - COMPETITIVE CHEMILUMINESCENT IMMUNOASSAY
TSH - SANDWICH CHEMILUMINESCENT IMMUNOASSAY
SUGGESTING THYRONORMALCY
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
: 13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode: I9946283
Lab code: 131029399/BT009
Page: 7 of 9
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.6 mg/dl 7 - 25
CREATININE - SERUM PHOTOMETRY 0.78 mg/dl 0.6-1.1
CALCIUM PHOTOMETRY 9.64 mg/dl 8.8-10.6
URIC ACID PHOTOMETRY 6.87 mg/dl 3.7 - 9.2
BUN / SR. CREATININE RATIO CALCULATED 11.03 Ratio 9:1-23:1
Please correlate with clinical conditions.
Method :
BUN - KINETIC UV ASSAY.
SCEM - CREATININE ENZYMATIC METHOD
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
Page: 8 of 9
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
: 13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Barcode: I9946283
Lab code: 131029399/BT009 Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
NAME
A CHATTERJEE(42Y/M)
REF. BY DR ANUTOSH CHAKRABORTY
TEST ASKED AAROGYAM 1

SAMPLE COLLECTED AT :
NIVA PARK, RAKSHITER MORE, PO- BORAL
Thyrocare
Shree Towers II, RAA/36, Raghunathpur,
VIP Road, Kolkata–700 059
PROCESSED AT :
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED mL/min/1.73 m2
Reference Range:-
111
> = 90 : Normal
60 - 89: Mild Decrease
45 - 59: Mild to Moderate Decrease
30 - 44: Moderate to Severe Decrease
15 - 29: Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to
routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and
report the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot
be measured easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race, and
sex. This provides easy to interpret information for the doctor and patient on the degree of renal impairment since it
approximately equates to the percentage of kidney function remaining. The application of the CKD-EPI equation together with
the other diagnostic tools in renal medicine will further improve the detection and management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular
filtration rate. Ann Intern Med. 2009;150(9):604-12.
Please correlate with clinical conditions.
Method:- CKD-EPI Creatinine Equation
~~ End of report ~~
SERUM
14 Oct 2018 09:18
13 Oct 2018 17:23
: 13 Oct 2018 09:56

Sample Type :
Report Released on (RRT)
Sample Received on (SRT)
Sample Collected on (SCT)
Dr. S.Bera MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode: I9946283
Lab code: 131029399/BT009

Page: 9 of 9